Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03297827 · ClinicalTrials.gov registry record
Cytokine Registry Database of Stroke Patients
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 12
- Enrollment target
NCT03297827 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 12 participants.
The verdict
NCT03297827 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Various molecules (cytokines: interleukins, interferons and neural proteins) found in human and animal blood are reported to be elevated in acute stroke (Ischemic and hemorrhagic). Cytokines can be pro-inflammatory or anti-inflammatory. There are studies confirming level changes in serum of humans in the setting of several rheumatologic and cardiovascular diseases. As new molecular markers (cytokines and neural tissue markers) are established in scientific literature, stroke scientists are interested to evaluate the role of these in the pathophysiology of stroke. Investigators intend to study the role of these molecules in the development of stroke. Acute stroke treatment has advanced considerably in the last 10 years with the establishment of comprehensive stroke centers and approval of neuro-interventional techniques. However, the molecular advancement in stroke pathogenesis has yet to reach a milestone in the world of stroke treatment. In our opinion, creating a database of acute stroke patients containing all pertinent medical demographics and clinical information along with the laboratory data, molecular levels of pertinent cytokines/neural factors from consenting patients, will help us define and delineate the most relevant molecules that are altered in acute stroke patients and can help us further improve us understanding of the role of these in acute stroke and thereby hopefully help in the improvement of our understanding and management of stroke. Moreover, analyzing the cytokines in stroke and ICH patients would help understand their role in the acute phase, which may become potential therapeutic adjuncts for tPA and endovascular thrombectomy.
Interventions
- OTHER Serum and Urine measurement of cytokines.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03297827
The ClinicalTrials.gov registry entry for NCT03297827 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serum and Urine measurement of cytokines. is the first listed.
NCT03297827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03297827 about?
NCT03297827 is a clinical study titled "Cytokine Registry Database of Stroke Patients". Various molecules (cytokines: interleukins, interferons and neural proteins) found in human and animal blood are reported to be elevated in acute stroke (Ischemic and hemorrhagic). Cytokines can be pro-inflammatory or anti-inflammatory. There are studies confirming level changes in serum of humans i...
What is the current status of trial NCT03297827?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-05-15. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03297827?
The interventions under investigation include: Serum and Urine measurement of cytokines. (OTHER).
Who is sponsoring clinical trial NCT03297827?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.